Abstract:The aberrant activation of complement system in several kidney diseases suggests that this pillar of innate immunity has a critical role in the pathophysiology of renal damage of different etiologies. A growing body of experimental evidence indicates that complement activation contributes to the pathogenesis of acute kidney injury (AKI) such as delayed graft function (DGF) in transplant patients. AKI is characterized by the rapid loss of the kidney's excretory function and is a complex syndrome currently lacking a specific medical treatment to arrest or attenuate progression in chronic kidney disease (CKD). Recent evidence suggests that independently from the initial trigger (i.e., sepsis or ischemia/reperfusions injury), an episode of AKI is strongly associated with an increased risk of subsequent CKD. The AKI-to-CKD transition may involve a wide range of mechanisms including scar-forming myofibroblasts generated from different sources, microvascular rarefaction, mitochondrial dysfunction, or cell cycle arrest by the involvement of epigenetic, gene, and protein alterations leading to common final signaling pathways [i.e., transforming growth factor beta (TGF-β), p16 ink4a , Wnt/β-catenin pathway] involved in renal aging. Research in recent years has revealed that several stressors or complications such as rejection after renal transplantation can lead to accelerated renal aging with detrimental effects with the establishment of chronic proinflammatory cellular phenotypes within the kidney. Despite a greater understanding of these mechanisms, the role of complement system in the context of the AKI-to-CKD transition and renal inflammaging is still poorly explored. The purpose of this review is to summarize recent findings describing the role of complement in AKI-to-CKD transition. We will also address how and when complement inhibitors might be used to prevent AKI and CKD progression, therefore improving graft function.

Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD

AKI: an increasingly recognized risk factor for CKD development and progression

Molecular Mechanisms of Kidney Injury and Repair

Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis

Mechanisms of injury and repair of acute kidney injury

Pathological mechanisms of kidney disease in ageing

How Acute Kidney Injury Contributes to Renal Fibrosis.

Mechanism and prevention of the transformation from AKI to CKD

Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease

Kidney Aging and Chronic Kidney Disease

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies

The Tubulointerstitial Pathophysiology of Progressive Kidney Disease

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury

Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition

Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease

Cellular Senescence, A Novel Therapeutic Target For Mesenchymal Stem Cells In Acute Kidney Injury

Tubular atrophy in the pathogenesis of chronic kidney disease progression

Autophagy in acute kidney injury and maladaptive kidney repair

In Vivo and In Vitro Analysis of Age-Associated Changes and Somatic Cellular Senescence in Renal Epithelial Cells

Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage

Cellular senescence in acute kidney injury: Target and opportunity